『Generate Integrating AI into Biologics』のカバーアート

Generate Integrating AI into Biologics

Generate Integrating AI into Biologics

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

Generate Biomedicines’ proprietary platform aims to use generative biology to upend traditional drug development across therapeutic protein modalities. Gevorg Grigoryan, chief technology officer, and Alex Snyder, chief medical officer, sit down with BI analysts Andrew Galler and Sam Fazeli to discuss the general state of AI in drug development and the unique capabilities of the Generate platform in developing novel biologics.

See omnystudio.com/listener for privacy information.

Generate Integrating AI into Biologicsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。